22 Feb Sinopharm offers to take Hong Kong-listed China-TCM private in nearly US$3 billion deal
Posted at 01:36h
in Asia
A consortium led by state-owned pharmaceuticals giant Sinopharm has revived a take-private bid for China Traditional Chinese Medicine Holdings (China-TCM), the Hong-Kong-listed drug maker said on Wednesday, valuing it at HK$23.16 billion (US$2.96 billion).China National Pharmaceutical, also known as Sinopharm, had in 2021 decided against...